Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair

BACKGROUND: Due to oral nano-delivery systems for the treatment of inflammatory bowel disease (IBD) are often failed to accumulated to the colonic site and could not achieve controlled drug release, it’s urgent to develop a microenvironment responsive drug delivery to improve therapy efficacy. Infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Fenting, Zeng, Fancai, Yu, Xin, Deng, Yiping, Zhang, Zongquan, Xu, Maochang, Ding, Nianhui, Tian, Ji, Li, Chunhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436423/
https://www.ncbi.nlm.nih.gov/pubmed/37596598
http://dx.doi.org/10.1186/s12951-023-02045-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436423/
https://www.ncbi.nlm.nih.gov/pubmed/37596598
http://dx.doi.org/10.1186/s12951-023-02045-4

Ejemplares similares